Douglass Brian Robb
Reporting owner on Forms 3, 4 and 5, CIK 2104618.
Douglass Brian Robb reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-10-08.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| RGEN · REPLIGEN CORPCIK 730272 | officer (CHIEF PRODUCT OFFICER) | 1 | 2026-10-08 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| RGEN · REPLIGEN CORPCommon Stock | 2026-10-06 | A granted | +700 | $0 | 8,685 | Form 4 |
| RGEN · REPLIGEN CORPStock Option (Right to Buy), derivative | 2026-10-06 | A granted | +675 | $0 | 675 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001628280-26-065462 | REPLIGEN CORP | 2026-10-08 |